Brind.

A researcher at the University of Copenhagen made a foundational discovery that led to drugs produced by Novo Nordisk.

1 report, 1 independent Updated Jul 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

University of Copenhagen Jens Juul Holst Denmark Novo Nordisk

Keep exploring

The entities involved

University of Copenhagen
public research university in Copenhagen, Denmark
- A large-scale study on tonsillectomy risks was conducted involving researchers from the University of Copenhagen and the University of Melbourne.Fri 04:50
Jens Juul Holst
Danish professor of metabolic research

Nothing else this week.
Denmark
country in Northern Europe and North America
- Zealand Pharma A/S appointed Danske Bank as lead manager for its share buy-back program in the Danish market.Mon 17:39
- An announced agreement grants the US permanent control over Greenland's security, driven by strategic US demands.Mon 17:14
Novo Nordisk
Danish pharmaceutical company
- BridgeBio and Novo Nordisk have both made filings under the KXCO Ontology.Mon 10:09
- CMS introduced the Medicare drug price negotiation program, and companies are facing challenges regarding pricing and market access.Mon 00:08

Related events

Coverage

Newest first; wire copies grouped

Jul 6wbur.org